OC
VIRX

Oarsman Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Oarsman Capital’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$161 – 902
2024
Q4 		$161 Hold
1,000
– – ﹤0.01% 891
2024
Q3 		$231 Buy
+1,000
New +$231 ﹤0.01% 893